Alpha Recherche Clinique

Futó vizsgálatok

• Toboroz

  A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

  NCT07717411· 3. fázis· Forrás

• Toboroz

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· 3. fázis· Forrás

• Toboroz

  AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  NCT07509307· 3. fázis· Forrás

• Toboroz

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  NCT07351045· 3. fázis· Forrás

• Toboroz

  A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  NCT07369011· 3. fázis· Forrás

• Toboroz

  A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  NCT07412756· 3. fázis· Forrás

• Toboroz

  A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  NCT07321886· 3. fázis· Forrás

• Toboroz

  A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

  NCT07202884· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07169578· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

  NCT07153471· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  NCT06976216· 3. fázis· Forrás

• Toboroz

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· 3. fázis· Forrás

• Fut, nem toboroz

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  NCT04437511· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Elhízás5 toboroz
• Alzheimer-kór3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Depresszió2 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Toboroz

  A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

  NCT07112339· 4. fázis· Forrás

• Lezárult

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06221969· 3. fázis· Forrás

• Lezárult

  A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06065540· 3. fázis· Forrás

• Lezárult

  A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

  NCT05931367· 3. fázis· Forrás

• Leállították

  A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

  NCT05732454· 2/3. fázis· Forrás

• Lezárult

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· 3. fázis· Forrás

• Leállították

  Open-label Extension for Phase 3 Clinical Trials of Simufilam

  NCT05575076· 3. fázis· Forrás

• Lezárult

  Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

  NCT05518123· 4. fázis· Forrás

• Lezárult

  Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

  NCT05509400· 4. fázis· Forrás

• Lezárult

  Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

  NCT04994483· 3. fázis· Forrás